Franck Touret
Franck Touret
Unité des virus émérgents
Verified email at
Cited by
Cited by
Of chloroquine and COVID-19
F Touret, X de Lamballerie
Antiviral research 177, 104762, 2020
In vitro screening of a FDA approved chemical library reveals potential inhibitors of SARS-CoV-2 replication
F Touret, M Gilles, K Barral, A Nougairède, J Van Helden, E Decroly, ...
Scientific reports 10 (1), 13093, 2020
Hydroxychloroquine use against SARS-CoV-2 infection in non-human primates
P Maisonnasse, J Guedj, V Contreras, S Behillil, C Solas, R Marlin, ...
Nature 585 (7826), 584-587, 2020
Prolonged infectivity of SARS-CoV-2 in fomites
B Pastorino, F Touret, M Gilles, X de Lamballerie, RN Charrel
Emerging infectious diseases 26 (9), 2256, 2020
Rapid incorporation of Favipiravir by the fast and permissive viral RNA polymerase complex results in SARS-CoV-2 lethal mutagenesis
A Shannon, B Selisko, NTT Le, J Huchting, F Touret, G Piorkowski, ...
Nature communications 11 (1), 4682, 2020
Heat inactivation of different types of SARS-CoV-2 samples: what protocols for biosafety, molecular detection and serological diagnostics?
B Pastorino, F Touret, M Gilles, X de Lamballerie, RN Charrel
Viruses 12 (7), 735, 2020
Favipiravir antiviral efficacy against SARS-CoV-2 in a hamster model
JS Driouich, M Cochin, G Lingas, G Moureau, F Touret, PR Petit, ...
Nature communications 12 (1), 1735, 2021
Favipiravir strikes the SARS-CoV-2 at its Achilles heel, the RNA polymerase
A Shannon, B Selisko, NTT Le, J Huchting, F Touret, G Piorkowski, ...
BioRxiv, 2020
A pan-serotype dengue virus inhibitor targeting the NS3–NS4B interaction
SJF Kaptein, O Goethals, D Kiemel, A Marchand, B Kesteleyn, JF Bonfanti, ...
Nature 598 (7881), 504-509, 2021
Evaluation of heating and chemical protocols for inactivating SARS-CoV-2
B Pastorino, F Touret, M Gilles, X de Lamballerie, RN Charrel
BioRxiv, 2020.04. 11.036855, 2020
Evaluation of chemical protocols for inactivating SARS-CoV-2 infectious samples
B Pastorino, F Touret, M Gilles, L Luciani, X de Lamballerie, RN Charrel
Viruses 12 (6), 624, 2020
Galectin-1-binding glycoforms of haptoglobin with altered intracellular trafficking, and increase in metastatic breast cancer patients
MC Carlsson, C Cederfur, V Schaar, CIA Balog, A Lepur, F Touret, ...
PloS one 6 (10), e26560, 2011
Dose rationale for favipiravir use in patients infected with SARS‐CoV‐2
P Eloy, C Solas, F Touret, F Mentré, D Malvy, X de Lamballerie, J Guedj
Clinical Pharmacology & Therapeutics 108 (2), 188-188, 2020
In vitro evaluation of therapeutic antibodies against a SARS-CoV-2 Omicron B. 1.1. 529 isolate
F Touret, C Baronti, HS Bouzidi, X de Lamballerie
Scientific reports 12 (1), 4683, 2022
Drugs against SARS‐CoV‐2: What do we know about their mode of action?
C Valle, B Martin, F Touret, A Shannon, B Canard, JC Guillemot, ...
Reviews in medical virology 30 (6), 1-10, 2020
In vitro activity of therapeutic antibodies against SARS-CoV-2 Omicron BA. 1, BA. 2 and BA. 5
F Touret, C Baronti, B Pastorino, PMS Villarroel, L Ninove, A Nougairède, ...
Scientific Reports 12 (1), 12609, 2022
SARS-CoV-2 viral dynamics in non-human primates
A Gonçalves, P Maisonnasse, F Donati, M Albert, S Behillil, V Contreras, ...
PLoS computational biology 17 (3), e1008785, 2021
Replicative fitness of a SARS-CoV-2 20I/501Y. V1 variant from lineage B. 1.1. 7 in human reconstituted bronchial epithelium
F Touret, L Luciani, C Baronti, M Cochin, JS Driouich, M Gilles, L Thirion, ...
MBio 12 (4), 10.1128/mbio. 00850-21, 2021
Preclinical evaluation of Imatinib does not support its use as an antiviral drug against SARS-CoV-2
F Touret, JS Driouich, M Cochin, PR Petit, M Gilles, K Barthélémy, ...
Antiviral research 193, 105137, 2021
Potent Inhibition of SARS-CoV-2 nsp14 N7-Methyltransferase by Sulfonamide-Based Bisubstrate Analogues
R Ahmed-Belkacem, M Hausdorff, A Delpal, P Sutto-Ortiz, AMG Colmant, ...
Journal of medicinal chemistry 65 (8), 6231-6249, 2022
The system can't perform the operation now. Try again later.
Articles 1–20